In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells

BACKGROUND: Lung cancer is the leading cause of cancer-related mortality. Therapies against non-small cell lung cancer (NSCLC) are particularly needed, as this type of cancer is relatively insensitive to chemotherapy and radiation therapy. We recently identified GGTI compounds that are designed to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimonjic, Drazen B, Chan, Lai N, Tripathi, Veenu, Lu, Jie, Kwon, Ohyun, Popescu, Nicholas C, Lowy, Douglas R, Tamanoi, Fuyuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639152/
https://www.ncbi.nlm.nih.gov/pubmed/23607551
http://dx.doi.org/10.1186/1471-2407-13-198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639152/
https://www.ncbi.nlm.nih.gov/pubmed/23607551
http://dx.doi.org/10.1186/1471-2407-13-198

Ejemplares similares